Galmeon
Therapy
Our
story
Galmeon Therapy (formerly Allyane):Regain Optimal Motor Function.
OUR MISSION
Our project began with a key observation: the central role of the brain in the care continuum.
Galmeon addresses a real public health challenge: accelerating the return to an active lifestyle (whether professional or athletic).
We turn knowledge into innovation, and innovation into impact, to build the future of healthcare.
- Diagnosis and Prevention: We are developing technology that enables healthcare professionals (orthopedic surgeons, sports medicine physicians, physical therapists, and osteopaths) to detect motor impairments in a standardized manner before and after surgery. Early identification of this condition makes it possible to recommend an appropriate treatment plan.
- Treatment: Using Galmeon Therapy (based on the principles of the Allyane Method), we are developing a solution for treating neuromotor disorders (musculoskeletal disorders, neurological conditions, urological conditions, TMJ disorders) by combining motor imagery exercises with the effects of low-frequency sounds.
- Tracking: We are developing software that allows healthcare practitioners to track their patients’ progress and attendance in order to maximize the results of each session.
Galmeon pays tribute to two pioneers in the history of neuroscience:
- Luigi Galvani(18th century), physicist and physician, pioneer of muscle electrophysiology
- Alcmaeon of Croton (5th century B.C.), the first Greek physician to recognize the central role of the brain
- We embody this continuity by combining historical roots with technological innovation.
OUR VALUES
- a strong scientific foundation, based on rigorous research protocols
- a technological approach that integrates neuroscience and personalized data analysis using artificial intelligence (AI)
- our commitment to developing our innovative technologies in France
Nov. 2025
The Creation of Galmeon
June 2026
Obtaining CE-MDR Marking & Launch of Our Galmeon Wave Medical Device
July 2026
Launch of the First Galmeon Center of Excellence—Lyon
0
years of R&D
0
%
of the medical device designed, developed, and manufactured in Auvergne-Rhône-Alpes
+
0